Drug Profile
Hepatitis A vaccine liposomal - Crucell
Alternative Names: Epaxal; Epaxal Junior; HAVpur; HAVpur Junior; IRIV-hepatitis A vaccine; Virohep-A; Virohep-A JuniorLatest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator Berna Biotech
- Developer Crucell; GSK
- Class Hepatitis A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis A
Most Recent Events
- 28 Feb 2011 Crucell completed enrolment in a phase III, long-term follow-up trial for Hepatitis A (Prevention, In infants) in Israel (NCT01307436)
- 22 Feb 2011 Crucell has been acquired by Johnson & Johnson
- 01 Jan 2010 Registered for Hepatitis A in Israel (IM)